Abstract #2111

Dynamic contrast enhanced imaging (DCE-MRI) combined with T1 and T2 mapping for differentiation between HCC and HM

Lili Fan¹, Ailian Liu¹, Jiazheng Wang², Liangjie Lin², Lihua Chen¹, Qingwei Song¹, Renwang Pu¹, Ying Zhao¹, Tao Lin¹, and Xue Ren¹

¹The First Affiliated Hospital of Dalian Medical University, Dalian, China, ²Philips Healthcare, Beijing, China

Liver cancer and liver metastases are the most common liver malignancies. The accurate diagnosis of hepatocellular carcinoma (HCC) and hepatic metastasis (HM) is of great significance to the choice of treatment options. We aimed to explore the value of dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) combined with T1 and T2 mapping to distinguish HCC from HM. Results showed that DCE combined with T1 and T2 mapping had the highest efficacy (AUC: 0.936; sensitivity: 81.8%; specificity: 100%).

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.